Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Agreement Study of 'TekiTrustTM SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit' and 'TekiTrustTM SARS-CoV-2 Neutralizing Antibody Detection Rapid Test'

NCT05338762 is registered in ClinicalTrials.gov with MiCo BioMed Co., Ltd. as lead sponsor.

NCT NCT05338762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05338762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Agreement Study of 'TekiTrustTM SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit' and 'TekiTrustTM SARS-CoV-2 Neutralizing Antibody Detection Rapid Test'
Lead sponsor
MiCo BioMed Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
June 2, 2021
Completion date
August 3, 2022
Enrollment
218 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 infection